Purple Total Assets from 2010 to 2024

PPBT Stock

USD 2.19 0.35 13.78%

Purple Biotech Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 32.4 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2014-12-31

Previous Quarter

36.1 M

Current Value

35.1 M

Quarterly Volatility

27.5 M

Yuan Drop

Covid

Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 208.9 K, Interest Expense of 2.3 M or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 84.89, Dividend Yield of 0.088 or PTB Ratio of 0.49. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.

Check out the analysis of Purple Biotech Correlation against competitors.

For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.

Latest Purple Biotech's Total Assets Growth Pattern

Below is the plot of the Total Assets of Purple Biotech over the last few years. Total assets refers to the total amount of Purple Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Purple Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Purple Biotech's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 44.3 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Purple Total Assets Regression Statistics

	Arithmetic Mean	23,847,500
	Geometric Mean	6,892,660
	Coefficient Of Variation	114.27
	Mean Deviation	22,149,600
	Median	14,718,000
	Standard Deviation	27,249,812
	Sample Variance	742.6T
	Range	83.5M
	R-Value	0.76
	Mean Square Error	339.9T
	R-Squared	0.57
	Significance	0
	Slope	4,620,238
	Total Sum of Squares	10395.7T

Purple Total Assets History

	2024	32.4 M
	2023	44.3 M
	2022	54.6 M
	2021	70.2 M
	2020	83.8 M
	2019	14.7 M
	2018	14.7 M

Other Fundumenentals of Purple Biotech

Intangibles To Total Assets

Purple Biotech Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Net Tangible Assets	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Short Term Debt	Intangible Assets	Good Will
Total Assets		1.0	-0.76	-0.77	0.57	0.28	0.58	0.97	0.89	0.77	0.96	0.76	0.97	0.92	-0.75	0.7	-0.18
Total Stockholder Equity	1.0		-0.73	-0.73	0.53	0.24	0.52	0.99	0.91	0.81	0.95	0.72	0.98	0.94	-0.73	0.73	-0.15
Net Debt	-0.76	-0.73		0.88	-0.82	-0.26	-0.78	-0.69	-0.56	-0.27	-0.75	-0.66	-0.68	-0.48	0.69	-0.27	0.51
Retained Earnings	-0.77	-0.73	0.88		-0.94	-0.43	-0.95	-0.64	-0.56	-0.21	-0.83	-0.79	-0.73	-0.48	0.83	-0.21	0.64
Accounts Payable	0.57	0.53	-0.82	-0.94		0.38	0.93	0.43	0.43	-0.01	0.69	0.68	0.56	0.25	-0.74	-0.07	-0.82
Net Receivables	0.28	0.24	-0.26	-0.43	0.38		0.45	0.21	-0.07	-0.09	0.29	0.65	0.18	0.12	-0.66	0.04	-0.12
Total Liab	0.58	0.52	-0.78	-0.95	0.93	0.45		0.43	0.34	-0.05	0.66	0.66	0.54	0.25	-0.71	-0.03	-0.75
Total Current Assets	0.97	0.99	-0.69	-0.64	0.43	0.21	0.43		0.89	0.85	0.89	0.65	0.96	0.96	-0.66	0.77	-0.08
Net Tangible Assets	0.89	0.91	-0.56	-0.56	0.43	-0.07	0.34	0.89		0.86	0.89	0.52	0.94	0.91	-0.52	0.64	-0.17
Short Term Investments	0.77	0.81	-0.27	-0.21	-0.01	-0.09	-0.05	0.85	0.86		0.68	0.34	0.81	0.95	-0.32	0.87	0.29
Property Plant Equipment	0.96	0.95	-0.75	-0.83	0.69	0.29	0.66	0.89	0.89	0.68		0.8	0.95	0.85	-0.79	0.59	-0.29
Current Deferred Revenue	0.76	0.72	-0.66	-0.79	0.68	0.65	0.66	0.65	0.52	0.34	0.8		0.69	0.58	-0.98	0.39	-0.24
Net Invested Capital	0.97	0.98	-0.68	-0.73	0.56	0.18	0.54	0.96	0.94	0.81	0.95	0.69		0.94	-0.71	0.69	-0.24
Net Working Capital	0.92	0.94	-0.48	-0.48	0.25	0.12	0.25	0.96	0.91	0.95	0.85	0.58	0.94		-0.57	0.86	0.09
Short Term Debt	-0.75	-0.73	0.69	0.83	-0.74	-0.66	-0.71	-0.66	-0.52	-0.32	-0.79	-0.98	-0.71	-0.57		-0.36	0.35
Intangible Assets	0.7	0.73	-0.27	-0.21	-0.07	0.04	-0.03	0.77	0.64	0.87	0.59	0.39	0.69	0.86	-0.36		0.47
Good Will	-0.18	-0.15	0.51	0.64	-0.82	-0.12	-0.75	-0.08	-0.17	0.29	-0.29	-0.24	-0.24	0.09	0.35	0.47

Click cells to compare fundamentals

About Purple Biotech Financial Statements

Purple Biotech shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Purple Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	44.3 M	32.4 M
Intangibles To Total Assets	0.63	0.32

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC